JACC: CardioOncology : Impact Factor & More
eISSN: 2666-0873pISSN: 2666-0873
Open AccessShare this on:
Key Metrics
CiteScore 
4.5
Eigenfactor
< 0.001
Impact Factor
10 - 15
SJR
Q3Oncology
SNIP
1.12
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on JACC: CardioOncology
JACC: CardioOncology Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ 
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | USD 2500 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | American College of Cardiology |
| Frequency | Quarterly |
| Publication Start Year | 2019 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in JACC: CardioOncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in JACC: CardioOncology
Rechallenge After Immune Checkpoint Inhibitors Myocarditis: Evidence and a Practical Framework: JACC Cardio-Oncology Primer.
- 19 Jun 2026
- JACC. CardioOncology
Exploring Overlooked Mediators Linking Myocardial Infarction to Hematologic Malignancies.
- 1 Jun 2026
- JACC. CardioOncology
Correction.
- 1 Jun 2026
- JACC. CardioOncology
Refining Vascular Biomarker-Guided Risk Stratification for Cancer Therapy-Related Cardiac Dysfunction.
- 1 Jun 2026
- JACC. CardioOncology
Association Between Clonal Hematopoiesis and Cardiometabolic Disease: A Systematic Review and Meta-Analysis.
- 1 Jun 2026
- JACC. CardioOncology
Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin Amyloidosis.
- 1 Jun 2026
- JACC. CardioOncology
Rechallenge After Immune Checkpoint Inhibitors Myocarditis: Evidence and a Practical Framework: JACC Cardio-Oncology Primer.
- 19 Jun 2026
- JACC. CardioOncology
Exploring Overlooked Mediators Linking Myocardial Infarction to Hematologic Malignancies.
- 1 Jun 2026
- JACC. CardioOncology
Correction.
- 1 Jun 2026
- JACC. CardioOncology
Refining Vascular Biomarker-Guided Risk Stratification for Cancer Therapy-Related Cardiac Dysfunction.
- 1 Jun 2026
- JACC. CardioOncology
Association Between Clonal Hematopoiesis and Cardiometabolic Disease: A Systematic Review and Meta-Analysis.
- 1 Jun 2026
- JACC. CardioOncology
Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin Amyloidosis.
- 1 Jun 2026
- JACC. CardioOncology
FAQs on JACC: CardioOncology
How long has JACC: CardioOncology been actively publishing? 
What is the publishing frequency of JACC: CardioOncology?
How many articles did JACC: CardioOncology publish last year?
What is the eISSN & pISSN for JACC: CardioOncology?
What is Citescore for JACC: CardioOncology?
What is SNIP score for JACC: CardioOncology?
What is the SJR for JACC: CardioOncology?
Who is the publisher of JACC: CardioOncology?
